CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival

The immunoregulatory role of type I and type II NKT cells in cancer and other diseases

(2014) Masaki Terabe et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Regulatory T cells, interleukin (IL)-6, IL-8, Vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma

(2013) Marianeve Polimeno et al.   BJU INTERNATIONAL

Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer

(2012) T. J. Webb et al.   CANCER RESEARCH

Interaction Between Invariant NKT Cells and Myeloid-derived Suppressor Cells in Cancer Patients

(2012) Francis Mussai et al.   JOURNAL OF IMMUNOTHERAPY

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma

(2010) Chuanhui Xu et al.   AMERICAN JOURNAL OF HEMATOLOGY

Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells

(2010) Y. Kawasaki et al.   GLYCOBIOLOGY

GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells

(2009) G. Sa et al.   CANCER RESEARCH

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

(2009) J. S. Ko et al.   CLINICAL CANCER RESEARCH

Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction

(2009) S. Biswas et al.   JOURNAL OF IMMUNOLOGY

GM1 and Tumor Necrosis Factor- , Overexpressed in Renal Cell Carcinoma, Synergize to Induce T-Cell Apoptosis

(2008) T. Das et al.   CANCER RESEARCH

Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

(2008) P. L. Crispen et al.   CLINICAL CANCER RESEARCH